Insulet
PODD
#1966
Rank
HK$79.69 B
Marketcap
HK$1,149
Share price
-6.16%
Change (1 day)
-53.89%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): HK$13.47

According to Insulet's latest financial reports the company's current EPS (TTM) is HK$33.17. In 2022 the company made an earnings per share (EPS) of HK$0.55 a decrease over its 2021 EPS that were of HK$1.80.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$13.472354.63%
2022HK$0.55-69.57%
2021HK$1.80109.09%
2020HK$0.86-38.89%
2019HK$1.41200%
2018HK$0.47-113.04%
2017-HK$3.61-9.8%
2016-HK$4.00-60.77%
2015-HK$10.1939.78%
2014-HK$7.2912.05%
2013-HK$6.51-23.15%
2012-HK$8.4710.2%
2011-HK$7.68-36.36%
2010-HK$12.08-36.63%
2009-HK$19.05-29.36%
2008-HK$26.97-86.74%
2007-HK$203.45-64.04%
2006-HK$565.75122.23%
2005-HK$254.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42 58.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$21.21-36.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$31.99-3.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$242.03 629.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$7.29-121.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$9.41-71.63%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$20.31-38.77%๐Ÿ‡บ๐Ÿ‡ธ USA